Literature DB >> 17385693

Prevalence of human papillomavirus types in women screened by cytology in Germany.

Stefanie J Klug1, Meike Hukelmann, Bettina Hollwitz, Nurgül Düzenli, Betti Schopp, Karl-Ulrich Petry, Thomas Iftner.   

Abstract

Incidence and mortality rates of cervical cancer are higher in Germany than in other Western European countries. Type-specific human papillomavirus (HPV) distribution was investigated for the first time in Germany in an epidemiological study including 8,101 women. Women above the age of 30 years, self-referring for cervical cancer screening, were enrolled in two study centers in Hannover (Northern Germany) and Tübingen (Southern Germany). Participants were screened by the Pap smear and the hybrid capture 2 (HC2) test using the high-risk probe. All samples that were positive by the HC2 test were genotyped using the prototype PGMY09/11 PCR line blot assay. Most women in the study population had a negative Pap smear (96.7%). Prevalence of high-risk type HPV detected by HC2 was 6.4% and prevalence of carcinogenic types detected by PGMY09/11 was 4.3%. Of the PGMY09/11 PCR-positive women, 70.2% had a single infection, 28.1% had multiple infections and 1.7% remained uncharacterized. 32 different HPV types were detected using PGMY09/11 PCR. HPV 16, 31, 52, 51, 18, and 45 were the most common carcinogenic types in the study population. Among women with histologically confirmed high-grade lesions HPV 16, 45, 58, 18, 31, 33, and 52 were the predominant types. These results provide valuable information for the management of HPV infections in Germany, both in terms of future strategies of screening and vaccination.

Entities:  

Mesh:

Year:  2007        PMID: 17385693     DOI: 10.1002/jmv.20863

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

1.  Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years.

Authors:  Yvonne Deleré; Melanie Schuster; Elena Vartazarowa; Thomas Hänsel; Ingke Hagemann; Simone Borchardt; Heike Perlitz; Achim Schneider; Sabine Reiter; Andreas M Kaufmann
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

2.  Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination.

Authors:  Sonja Fischer; Marcus Bettstetter; Andrea Becher; Marlene Lessel; Cyril Bank; Matthias Krams; Ingrid Becker; Arndt Hartmann; Wolfgang Jagla; Andreas Gaumann
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

3.  Early detection of cervical carcinomas: finding an overall approach.

Authors:  Nicolas Wentzensen; Stefanie J Klug
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

Review 4.  The impact of human papillomavirus vaccination on cervical cancer prevention efforts.

Authors:  L Stewart Massad; Mark Einstein; Evan Myers; Cosette M Wheeler; Nicolas Wentzensen; Diane Solomon
Journal:  Gynecol Oncol       Date:  2009-05-01       Impact factor: 5.482

5.  Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis.

Authors:  Nina Buttmann-Schweiger; Stefanie J Klug; Alexander Luyten; Bernd Holleczek; Florian Heitz; Andreas du Bois; Klaus Kraywinkel
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

6.  Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases.

Authors:  Seiichiro Mori; Rika Kusumoto-Matsuo; Yoshiyuki Ishii; Takamasa Takeuchi; Iwao Kukimoto
Journal:  Virol J       Date:  2014-01-24       Impact factor: 4.099

7.  Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.

Authors:  Karl Ulrich Petry; Alexander Luyten; Annika Justus; Angelika Iftner; Sarah Strehlke; Axel Reinecke-Lüthge; Elisabeth Grunwald; Renate Schulze-Rath; Thomas Iftner
Journal:  BMC Infect Dis       Date:  2013-03-13       Impact factor: 3.090

8.  Seroprevalence of 34 human papillomavirus types in the German general population.

Authors:  Kristina M Michael; Tim Waterboer; Peter Sehr; Annette Rother; Ulrich Reidel; Heiner Boeing; Ignacio G Bravo; Jörg Schlehofer; Barbara C Gärtner; Michael Pawlita
Journal:  PLoS Pathog       Date:  2008-06-20       Impact factor: 6.823

9.  Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2).

Authors:  Stefanie Castell; G Krause; M Schmitt; M Pawlita; Y Deleré; N Obi; D Flesch-Janys; Y Kemmling; A M Kaufmann
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2014-11       Impact factor: 1.513

10.  Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads.

Authors:  Zhengrong Sun; Rong Zhang; Zhonghua Liu; Chao Liu; Xiulin Li; Weiqiang Zhou; Lianxia Yang; Qiang Ruan; Xu Zhang
Journal:  BMC Cancer       Date:  2015-11-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.